[1] |
吴力群,邱法波,张顺,等.原发性肝细胞癌R0切除标准的探讨.中国实用外科杂志, 2011, 31(11):1027-1030.
|
[2] |
Tung-Ping Poon R, Fan ST, Wong J. Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann Surg, 2000, 232(1):10-24.
|
[3] |
王玮,陈敏山,李锦清.肝细胞癌根治术后复发的预测与防治[J/CD].中华普通外科学文献:电子版, 2009, 3(2):95-99.
|
[4] |
El-Tanani MK, Campbell FC, Kurisetty V, et al. The regulation and role of osteopontin in malignant transformation and cancer. Cytokine Growth Factor Rev, 2006, 17(6):463-474.
|
[5] |
孙长宇,张贤强,江河清,等.肝细胞性肝癌组织中HBX蛋白与骨桥蛋白的表达.郑州大学学报:医学版, 2009, 44(3):579-582.
|
[6] |
El-Din Bessa SS, Elwan NM, Suliman GA, et al. Clinical significance of plasma osteopontin level in Egyptian patients with hepatitis C virus-related hepatocellular carcinoma. Arch Med Res, 2010, 41(7):541-547.
|
[7] |
张辉,应敏刚,任宁,等.肝细胞癌患者血浆骨桥蛋白表达水平与术后复发及预后的关系.中外医疗, 2008, 27(5):10-13.
|
[8] |
Pan HW, Ou YH, Peng SY, et al. Overexpression of osteopontin is associated with intrahepatic metastasis, early recurrence, and poorer prognosis of surgically resected hepatocellular carcinoma. Cancer, 2003, 98(1):119-127.
|
[9] |
Qin LX, Tang ZY, Ma ZC, et al. P53 immunohistochemical scoring: an independent prognostic marker for patients after hepatocellular carcinoma resection. World J Gastroenterol, 2002, 8(3):459-463.
|
[10] |
Jeng KS, Sheen IS, Chen BF, et al. Is the p53 gene mutation of prognostic value in hepatocellular carcinoma after resection? Arch Surg, 2000, 135(11):1329-1333.
|
[11] |
Ariizumi S, Takasaki K, Yamamoto M, et al. Multicentric hepatocellular carcinomas tend to grow in more damaged segments of the liver. J Gastroenterol, 2000, 35(6):441-444.
|
[12] |
Poon RT, Ng IO, Lau C, et al. Serum vascular endothelial growth factor predicts venous invasion in hepatocellular carcinoma: a prospective study. Ann Surg, 2001, 233(2):227-235.
|
[13] |
Chakraborty G, Jain S, Kundu GC. Osteopontin promotes vascular endothelial growth factor-dependent breast tumor growth and angiogenesis via autocrine and paracrine mechanisms. Cancer Res, 2008, 68(1):152-161.
|
[14] |
Hirama M, Takahashi F, Takahashi K, et al. Osteopontin overproduced by tumor cells acts as a potent angiogenic factor contributing to tumor growth. Cancer Lett, 2003, 198(1):107-117.
|
[15] |
Takahashi F, Akutagawa S, Fukumoto H, et al. Osteopontin induces angiogenesis of murine neuroblastoma cells in mice. Int J Cancer, 2002, 98(5):707-712.
|
[16] |
Ye QH, Qin LX, Forgues M, et al. Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning. Nat Med, 2003, 9(4):416-423.
|
[17] |
Gotoh M, Sakamoto M, Kanetaka K, et al. Overexpression of osteopontin in hepatocellular carcinoma. Pathol Int, 2002, 52(1):19-24.
|
[18] |
林帆,李瑜元,夏金堂,等.骨桥蛋白基因沉默对肝癌侵袭转移的抑制作用.中华肝脏病杂志, 2009, 17(6):422-425.
|
[19] |
朱晓群,叶青海,雷科峰,等.特异性小干扰性RNA降低骨桥蛋白基因表达对肝癌细胞侵袭性的影响.中华肿瘤杂志, 2006, 28(6):404-407.
|
[20] |
Cheng J, Huo DH, Kuang DM, et al. Human macrophages promote the motility and invasiveness of osteopontin-knockdown tumor cells. Cancer Res, 2007, 67(11):5141-5147.
|